2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO

Autor:	Alfonso Yubero, Aranzazu Barquín, Lydia Gaba, Bella Pajares, Piedad Reche, Carmen Salvador, Jesús Alarcón, Luis Manso, Raúl Marquez, Jose Fuentes, Julia Madani, Manuel Costenla, Maria Gutierrez-Toribio, Purificacion Estevez-García, Ana Santaballa, Luisa Sanchez-Lorenzo, Julia Calzas, Ana Herrero, Alvaro Taus, Antonio Gonzalez-Martin
Rok vydání:	2022
Zdroj:	Ovarian cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::402b1db1c565c75905d431f677a34f83 https://doi.org/10.1136/ijgc-2022-esgo.513 Zobrazit plný text záznamu